Kolon adds TONXBIO as holding-company subsidiary after Kolon Pharm spinoff
Bitget2026/10/12 08:22- Kolon Corp. folded TONXBIO into its holding-company structure following Kolon Pharm’s spinoff reorganization.
- The holding company took a 40% stake, equal to 532,544 shares, effective Oct. 2, 2026.
- Investment book value totaled 16,422 million, representing 2.16% of Kolon Corp.’s total assets based on year-end 2025 standalone statements.
- TONXBIO’s latest summarized financials showed assets of 39,672 million, liabilities of 770 million, equity of 38,902 million.
- The transaction lifted the group’s total number of subsidiaries to 10 from 9.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
British Pound: Wider trading range expected against US Dollar – UOB

Japan's Gradual "Capital Reflow": Japanese Bond Purchases Heat Up, No Major Retreat from Overseas Assets
Several leading Japanese asset management companies are expected to announce plans to increase their holdings of domestic bonds. The market is closely watching whether they will further reduce overseas assets to promote capital inflow back into Japan.
Korean stock earnings season starts next week; JPMorgan says storage stocks are entering a “season of expectation reset,” corrections present buying opportunities
JPMorgan believes that there is a divergence in perception among investors regarding the sustainability of AI spending and the underlying supply-demand fundamentals, and that excessive market sentiment has created an entry window for "duration trades"—betting on a "longer and higher" storage upcycle. The bank recommends overweight positions in industry leaders such as Samsung Electronics, SK Hynix, and Kioxia. The key verification point will be the earnings season starting from October 19.

British Pound holds gains as UK GDP and Industrial Production beat expectations
